56100-67-5Relevant academic research and scientific papers
PHARMACOLOGICAL AGENTS FOR TREATING OCULAR DISEASES
-
Page/Page column 44-46, (2019/10/29)
Methods of treating presbyopia or cataract in a subject in need thereof are provided, The methods require administering to the subject an effective amount of a composition comprising a compound that inhibits the formation of high molecular weight aggregat
Synthesis and X-Ray Crystal Structure of 8,9-Dimethoxy-4-methyl-3-phenyl-2,3,5,6-tetrahydropyrroloisoquinolinium Iodide
Bailey, T. Sam,Bremner, John B.,Pelosi, Luciana,Skelton, Brian W.,White, Allan H.
, p. 1437 - 1446 (2007/10/02)
N-Methylation of 6,7-dimethoxy-1-(2'-phenylcyclopropyl)-3,4-dihydroisoquinoline (3b) with iodomethane in refluxing acetone gave the modified Cloke rearrangement product, 8,9-dimethoxy-4-methyl-3-phenyl-2,3,5,6-tetrahydropyrroloisoquinolinium iodide (5b), a new derivative of the pyrroloisoquinoline skeleton, together with the methiodide salt (4b) of (3b).The structure of (5b) was confirmed by X-ray crystallographic analysis.
